How employers can manage weight-related health costs when GLP-1 coverage isn’t affordable
Employers don’t have to wait for GLP-1 costs to come down to address weight-related health risks. A comprehensive employer weight management strategy can start with behavior change, earlier intervention, personalized clinical support, and better measurement of health outcomes and total cost of care. For many employers, broad coverage of GLP-1 medications for weight management isn’t […]
What makes an obesity care benefit built to last? 5 characteristics employers should look for
Employers have spent the last few years asking one question: should we cover GLP-1s? Today, the more important question is different: how do we build an obesity care strategy that still works over the long term? A sustainable employer obesity care benefit bridges wellness and chronic disease management, integrates GLP-1 medications with behavior change, adapts […]
10 questions employers should ask before making GLP-1 coverage decisions
GLP-1 medications have changed the conversation around weight management. For employers, the question is no longer simply whether these medications work or whether to cover them. It’s how to make a coverage decision that fits the needs of their population and supports better outcomes over time. That means looking beyond the pharmacy line item. Before […]
The benefits blind spot: The missing middle and why wellness and disease management aren’t enough anymore
For years, employer health strategies have largely been built around two populations: employees who are generally healthy and may engage with wellness programs designed to help them stay that way, and employees with diagnosed conditions who may qualify for disease management or more intensive clinical support. But what happens to those in between? Consider the […]
The inflammation obesity connection: The cost driver employers aren’t talking about
When employers think about obesity, the conversation usually centers on weight: how much weight employees lose, whether GLP-1 medications are covered, and the impact on pharmacy spending. Those are important discussions, and they’ll likely remain central as obesity treatment continues to evolve. But another conversation is gaining momentum alongside them: the role of chronic inflammation. Weight is what we see, […]
The future of obesity benefits: 5 trends employers need to know beyond GLP-1s
Discover five obesity care trends shaping employer benefits, from personalized treatment and GLP-1 innovation to behavior change and long-term health outcomes.
Bend it like behavior change: addressing the cost curve in employee health
GLP-1s can be incredibly effective. They’re also changing expectations quickly. Which means benefits leaders are trying to both support people who want care that works and keep the benefit financially sustainable (so access doesn’t disappear in a year).
GLP-1 access without governance is not a strategy: 6 steps to better outcomes
GLP-1s changed weight management from wellness to medical spend. Here’s what’s next: smarter obesity benefits strategy, better support on and off meds, and practical clinical pathways for employers.
How benefits consultants can lead in the GLP-1 era
GLP-1s changed weight management from wellness to medical spend. Here’s what’s next: smarter obesity benefits strategy, better support on and off meds, and practical clinical pathways for employers.
The future of weight loss is not weight loss: The next evolution of GLP-1s for employers
GLP-1s changed weight management from wellness to medical spend. Here’s what’s next: smarter obesity benefits strategy, better support on and off meds, and practical clinical pathways for employers.